Form 4: Jasper Therapeutics Director Scott Brun Granted Power of Attorney, Acquires Stock Options

Scott Brun, a director at Jasper Therapeutics, granted power of attorney to Ronald Martell and Herb Cross and acquired 7,500 stock options.

Summary

• Scott Brun, a director of Jasper Therapeutics, Inc., has granted power of attorney to Ronald Martell and Herb Cross to execute and file Forms 3, 4, 5, and 144 on his behalf.
• This power of attorney covers transactions related to Section 16(a) of the Securities Exchange Act of 1934 and Rule 144 under the Securities Act of 1933.
• The power of attorney remains in effect until Brun is no longer required to file these forms or until he revokes it in writing.
• Additionally, Scott Brun acquired 7,500 stock options with an exercise price of $25.41 on June 6, 2024, exercisable from June 6, 2025, and expiring on June 6, 2034.

Sentiment

Score: 6

Explanation: The document is neutral, detailing routine administrative and compensation matters. The acquisition of stock options is generally viewed positively, but it's a standard practice.

Industry Context

The granting of power of attorney for SEC filings is a routine administrative procedure. The acquisition of stock options is a common form of executive compensation.

Stakeholder Impact

• Shareholders may view the granting of stock options as a positive incentive for the director.
• The power of attorney ensures compliance with SEC regulations.

Key Dates